Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 102907
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.102907
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.102907
Table 5 Comparison of adverse reactions between two groups, n (%)
Time point | Group | Nausea | Vomit | Headache | Hypotension | Local numbness | χ2 | P value |
6 hours after surgery | Observation | 3 (5.00) | 2/3.33 | 1 (1.67) | 4 (6.67) | 2 (3.33) | 1.087 | 0.9 |
Control | 4 (6.67) | 3/5.00 | 2 (3.33) | 5 (8.33) | 3 (5.00) | |||
24 hours after surgery | Observation | 2 (3.33) | 1/1.67 | 0 | 2 (3.33) | 1 (1.67) | 2.066 | 0.733 |
Control | 3 (5.00) | 2/3.33 | 1 (1.67) | 3 (5.00) | 2 (3.33) | |||
48 hours after surgery | Observation | 1 (1.67) | 1/1.67 | 0 | 1 (1.67) | 1 (1.67) | 1.667 | 0.798 |
Control | 2 (3.33) | 2/3.33 | 1 (1.67) | 2 (3.33) | 2 (3.33) |
- Citation: Zhang X, Xiang GR, Wang ZX, Peng MQ, Li M. Effect of dexmedetomidine-ropivacaine transversus abdominis plane block on analgesia and cognitive impairment risk in colorectal cancer surgery. World J Gastrointest Surg 2025; 17(6): 102907
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/102907.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.102907